# Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

> **NCT00697463** · PHASE2,PHASE3 · COMPLETED · sponsor: **Columbia University** · enrollment: 22 (actual)

## Conditions studied

- Menopause
- Fracture
- Osteoporosis

## Interventions

- **DRUG:** Teriparatide (PTH 1-34)

## Key facts

- **NCT ID:** NCT00697463
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-20
- **Primary completion:** 2012-01-03
- **Final completion:** 2012-01-03
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00697463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00697463, "Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00697463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*